CAPTRUST FINANCIAL ADVISORS - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 184 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2022$010
-23.1%
0.00%
Q3 2021$0
-100.0%
13
-92.1%
0.00%
Q2 2021$3,000
-88.0%
165
-84.9%
0.00%
Q1 2021$25,000
+525.0%
1,096
+564.2%
0.00%
Q4 2020$4,000
-42.9%
1650.0%0.00%
Q3 2020$7,000
-12.5%
1650.0%0.00%
Q2 2020$8,000
-57.9%
165
-41.1%
0.00%
-100.0%
Q3 2019$19,000
+216.7%
280
+460.0%
0.00%
Q3 2018$6,000500.00%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders